Boston Scientific (BSX) Stock: Why Shares Drop 8% Despite Earnings Beat

TLDR Boston Scientific reported Q4 adjusted earnings of 80 cents per share, beating analyst estimates of 78 cents Net sales reached $5.29 billion with 12.7% organic growth, slightly above Wall Street expectations Q1 guidance disappointed with projected growth of 8.5% to 10% versus analyst expectations of 9.8% Electrophysiology division underperformed with $890 million in sales [...]

The post Boston Scientific (BSX) Stock: Why Shares Drop 8% Despite Earnings Beat appeared first on Blockonomi.